Amyotrophic Lateral Sclerosis-3

download Amyotrophic Lateral Sclerosis-3

of 22

description

sclerosis-3

Transcript of Amyotrophic Lateral Sclerosis-3

  • Amyotrophic Lateral SclerosisAli Nasim MDFellow, Neuroradiology Division at UNC

  • What is ALS?A-myo-trophic = no-muscle-nourishment

    Lateral Sclerosis refers to involvement of the lateral corticospinal tracts.

    ALS is a degeneration of somatic motor neurons extending from upper motor cortical pyramidal neurons to lower motor neurons of the brainstem and cord.

  • History of ALS 1869 - First described in publication by Dr. Jean-Martin Charcot, in Paris.

    1881 - Lectures translated into English

  • ALS: Clinical FindingsSymptoms:

    Upper motor - Babinski, spasticity, hyperreflexia.

    Lower motor - asymmetric muscle weakness, atrophy, fasciculations

    Bulbar signs - dysphagia, slurred speech

  • ALS: Clinical FindingsTypes:

    Classic - UMN and LMN

    Only UMN or only LMN

    Predominantly bulbar form - worse prognosis

    Familial - 15-20%

    5600 cases per year in the US, 40-70 y/o, M:F 2:1

  • ALS: Clinical Findings Progresses distal to proximal, with complete disability within 10 yrs

    20% of patients survive >5 yrs

    Familial and juvenile onset survive 20-30 yrs after diagnosis

  • ALS: Clinical Findings Revised El Escorial World Federation of Neurology criteria:

    Evidence of LMN degeneration by clinical, electrophysiological, or neuropathological examination

    Evidence of UMN degeneration by clinical examination

    Progressive spread of symptoms or signs within a region or to other regions (The body is divided into four regions: cranial, cervical, thoracic and lumbosacral)

    Absence of electrophysiological, pathological or neuroimaging evidence of other disease processes.

  • ALS: Imaging FindingsCan have normal imaging

    Focal atrophy in chronic cases

    T2/FLAIR hyperintensity extending along the corticospinal tract from corona radiata to the brainstem

    Contrast enhancement - ?

    Deposition of iron in affected cortex

  • ALS: Imaging FindingsEarly unilateral (left) ALS involvement in a patient with associated callosal agenesis.

  • ALS: Imaging FindingsCurved MPR: Corticospinal Tract extension

  • ALS: Imaging FindingsEnhancement is atypical but occasionally seen.

  • ALS: Imaging FindingsBilateral high T2 signal in corticospinal tracts.

  • ALS: Imaging FindingsIncreased iron (low T2 signal) deposition in the gray matter of the peri-Rolandic regions which underlying high signal in the white matte and dilatation of the adjacent cortical sulci.

  • ALS: Imaging FindingsFLAIR images shows high signal in the cortico-spinal tracts due to Wallerian degeneration.

  • ALS: Imaging FindingsMR Spectroscopy:

    Decreased NAA/Cr ratio

    Increased choline and myoinositol

    Decreased glutamate in the precentral gyrus and peri-rolandi white matter

  • ALS: Pathology Loss of cortical pyramidal motor neurons and gliosis

    Corticospinal tracts with variable patterns of degeneration

    Precentral gyrus atrophy

  • ALS: Pathophyiology Cause of Spontaneous ALS unknown

    Single gene mutations can lead to selective motor neuron loss

    Glutamate excitotoxicity (etiology unknown)

  • ALS: Pathophyiology

    Familial ALS:

    Copper/Zinc Superoxide dismutase (SOD1)gene mutation found to be associated with 20% of familial ALS

    Gain of function mutation

  • ALS: Interesting Info Reports of populations with increased incidence, most notably the Chamarro people of Guam (ALS-PCD)

    Incidence ranging 140-400 cases / 100,000 (nml 0.5-2 cases/ 100,00)

    Recent theory is that this was due to bat consumption and exposure to BMMA excitotoxins.

  • ALS: Notable People AffectedLou Gehrig Stephen Hawking Jon Stone

  • ALS: TreatmentRiluzole - glutamate release inhibitor

    -Has been shown to increase NAA/Cr ratio

    Symptom treatment - ventilation, anti-spastic medications

  • References Kalra, S. et al, Neuroimaging in Amyotrophic Lateral Sclerosis. ALS and Other Motor Neuron Disorders. 2003:4 243-248.

    Kalra, S. et al, Gabapentin Therapy for Amyotrophic Lateral Sclerosis: Lack of Improvement in Neuronal Integrity Shown by MR Spectroscopy AJNR, Mar 2003; 24: 476 - 480.

    Bowen, B. , MR Imaging and Localized Proton Spectroscopy of the Precentral Gyrus in Amyotrophic Lateral Sclerosis AJNR, Apr 2000; 21: 647 - 658.

    statDx.com

    archives.org

    athiestnexus.org

    sabine.k12.la.us

    muppet.wikia.com